MedPath
NMPA Approval

Fexofenadine Hydrochloride

国药准字H20070133

February 24, 2022

国药准字H20070133

Drug Information

盐酸非索非那定

化学药品

February 24, 2022

Company Information

Applicant Company

Manufacturing Company

四川省德阳市广汉市台北路西二段8号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

盐酸非索非那定 - NMPA 批准文号 | MedPath